Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 6
University of Oxford, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
University of Oxford, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
University of Oxford, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
University of Oxford, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10
University of Oxford, Medical Devices Deals, 2011 to YTD 2017 12
University of Oxford, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 13
University of Oxford, Pharmaceuticals & Healthcare, Deal Details 17
Venture Financing 17
Cytox Raises USD3.3 Million in Venture Financing 17
Adaptimmune Raises USD104 Million in Series A Venture Financing 18
Chronos Therapeutics Raises US$13 Million In Venture Financing 20
Partnerships 21
Novo Nordisk Enters into Research Agreement with University of Oxford 21
Evotec Partners with University of Oxford, Oxford University Innovation and Oxford Sciences Innovation 22
MDNA Life Sciences Enters into Agreement with University of Oxford 23
Idogen Enters into Agreement with University of Oxford 24
Sound Pharma to Partner with University of Oxford 25
Summit Therapeutics Enters into Agreement with University of Oxford 26
Genomics Enters into Agreement with Oxford University and Oxford University Hospitals NHS 27
Wave Life Sciences Enters into Research Agreement with University of Oxford 28
Cell Therapy Catapult, Plasticell and University of Oxford Enter into Agreement 29
Emergent BioSolutions Signs Agreement with Oxford University, GlaxoSmithKline and NIAID for the Production of an MVA Ebola Zaire Vaccine Candidate 30
MicroPharm Partners with Public Health England and University of Oxford 32
Chan Soon-Shiong Institute Forms Joint Venture with University of Oxford 33
SBI Pharma Enters into Research Agreement with University of Oxford 34
Bayer HealthCare Enters Co-Development Agreement with University of Oxford 35
MRC Technology Enters Into Co-Development Agreement With Oxford University 36
Creeyan Labs Enters Into Co-Development Agreement With Oxford University 37
iQur Enters Into Co-Development Agreement With Edward Jenner Institute For Malaria Vaccine 38
Emerald Biostructures Enters Into Co-Marketing Agreement With University of Oxford For PiMS Technology 39
Population Genetics Technologies Enters Into Co-Development Agreement With University of Oxford 40
Novo Nordisk Enters Into Co-Development Agreement With Oxford University 41
UCB Enters Into Co-Development Agreement With Oxford University 42
ValiRx Enters Into Co-Development Agreement With Oxford University 43
Cancer Research UK Enters Into Joint Venture Agreement With University Of Oxford And Oxford Radcliffe 44
Licensing Agreements 45
Nightstar Therapeutics Enters into Licensing Agreement with Oxford University Innovation 45
NightstaRx Enters into Licensing Agreement with Oxford University 46
NightstaRx Expands Licensing Agreement with Isis Innovation 47
NightstaRx Enters into Licensing Agreement with Oxford University Innovation 48
Vaccitech Enters into Licensing Agreement with University of Oxford 49
Rogne Bioscience Enters Into Licensing Agreement with Isis Innovation 50
ExpreS2ion Biotech Enters Into Licensing Agreement With University of Oxford For ExpreS2 51
Oxford Nutrascience Enters Into Licensing Agreement With Isis Innovation 52
Equity Offering 53
Summit Therapeutics Raises Funds in Private Placement of Shares upon Exercise of Warrants 53
Evox Therapeutics Spin-Off from University of Oxford 54
Perspectum Diagnostics Raises USD5 Million in Financing 55
Oxstem Spin-Off from University of Oxford 56
University of Oxford – Key Competitors 57
University of Oxford – Key Employees 58
University of Oxford – Locations And Subsidiaries 59
Head Office 59
Other Locations & Subsidiaries 59
Joint Venture 60
Recent Developments 61
Government and Public Interest 61
Nov 06, 2017: Helmsley Charitable Trust Awards $52 Million to Support the Global Platform for the Prevention of Autoimmune Diabetes 61
Sep 06, 2017: Treating insomnia may reduce mental health problems 63
Aug 29, 2017: Oxford Scientists to Investigate New Early Warning Scan for Heart Attacks 64
Apr 04, 2017: Synthego Awards Synthetic sgRNA Grant to University of Oxford for CRISPR Research Applications in the UK 66
Dec 14, 2016: Oxford Genetics secures £1.61m Innovate UK grant to establish next-generation bioproduction technologies 67
Dec 13, 2016: New research provides hope for patients with hard-to-treat breast cancer 68
Nov 23, 2016: University of Oxford team receives research grant from Family Larsson-Rosenquist Foundation to improve health and development of preterm infants 69
Nov 08, 2016: Scientists Identify key Evolutionary Catalyst for Antibiotic Resistance 70
Sep 19, 2016: Trial offers hope of a treatment for spinal muscular atrophy 71
Sep 15, 2016: Monitoring prostate cancer offers the same survival chance as surgery or radiotherapy over 10 years, but treatment reduces risk of cancer progression 72
Aug 03, 2016: Rapid test for bacterial infection reduces antibiotic use 74
Jul 20, 2016: Rare mutations in bowel cancer may identify patients with a better prognosis 75
May 27, 2016: Genes that increases children’s risk of blood infection identified 76
May 05, 2016: Oxford study finds virtual reality can help treat severe paranoia 77
May 04, 2016: Statin treatment before heart surgery does not prevent heart damage or atrial fibrillation 79
Apr 28, 2016: NightstaRx Reports Long-Term Benefits of Gene Therapy for Inherited Form of Progressive Blindness, as Published in the New England Journal of Medicine 81
Apr 28, 2016: Gene therapy shows long-term benefit for treating rare blindness 82
Apr 27, 2016: Mindfulness-based cognitive therapy linked to reduced depressive relapse risk 84
Apr 26, 2016: Side effects of statins investigated in new trial 85
Apr 12, 2016: Biomarker discovery offers hope for new TB vaccine 86
Mar 24, 2016: First virus genome analysis gives new insights into Brazilian Zika outbreak 87
Mar 17, 2016: Scientists pinpoint molecular signal that drives and enables spinal cord repair 88
Feb 12, 2016: Genome studies can help identify lifestyle risks for diseases 89
Feb 05, 2016: Protein that switches cancers from inflammation to proliferation identified 90
Product News 91
Jun 08, 2016: Bubbly drinks inspire more effective cancer treatment 91
Mar 31, 2016: Ludger: Site-specific N-glycosylation analysis of HIV-1 Envelope Glycoprotein 92
Other Significant Developments 93
Jun 14, 2016: Oxford spinout OMass Technologies provides native mass spectrometry to pharma and biotech 93
Appendix 94
Methodology 94
About GlobalData 94
Contact Us 94
Disclaimer 94
University of Oxford, Pharmaceuticals & Healthcare, Key Facts 2
University of Oxford, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
University of Oxford, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
University of Oxford, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
University of Oxford, Deals By Therapy Area, 2011 to YTD 2017 10
University of Oxford, Medical Devices Deals, 2011 to YTD 2017 12
University of Oxford, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 13
Cytox Raises USD3.3 Million in Venture Financing 17
Adaptimmune Raises USD104 Million in Series A Venture Financing 18
Chronos Therapeutics Raises US$13 Million In Venture Financing 20
Novo Nordisk Enters into Research Agreement with University of Oxford 21
Evotec Partners with University of Oxford, Oxford University Innovation and Oxford Sciences Innovation 22
MDNA Life Sciences Enters into Agreement with University of Oxford 23
Idogen Enters into Agreement with University of Oxford 24
Sound Pharma to Partner with University of Oxford 25
Summit Therapeutics Enters into Agreement with University of Oxford 26
Genomics Enters into Agreement with Oxford University and Oxford University Hospitals NHS 27
Wave Life Sciences Enters into Research Agreement with University of Oxford 28
Cell Therapy Catapult, Plasticell and University of Oxford Enter into Agreement 29
Emergent BioSolutions Signs Agreement with Oxford University, GlaxoSmithKline and NIAID for the Production of an MVA Ebola Zaire Vaccine Candidate 30
MicroPharm Partners with Public Health England and University of Oxford 32
Chan Soon-Shiong Institute Forms Joint Venture with University of Oxford 33
SBI Pharma Enters into Research Agreement with University of Oxford 34
Bayer HealthCare Enters Co-Development Agreement with University of Oxford 35
MRC Technology Enters Into Co-Development Agreement With Oxford University 36
Creeyan Labs Enters Into Co-Development Agreement With Oxford University 37
iQur Enters Into Co-Development Agreement With Edward Jenner Institute For Malaria Vaccine 38
Emerald Biostructures Enters Into Co-Marketing Agreement With University of Oxford For PiMS Technology 39
Population Genetics Technologies Enters Into Co-Development Agreement With University of Oxford 40
Novo Nordisk Enters Into Co-Development Agreement With Oxford University 41
UCB Enters Into Co-Development Agreement With Oxford University 42
ValiRx Enters Into Co-Development Agreement With Oxford University 43
Cancer Research UK Enters Into Joint Venture Agreement With University Of Oxford And Oxford Radcliffe 44
Nightstar Therapeutics Enters into Licensing Agreement with Oxford University Innovation 45
NightstaRx Enters into Licensing Agreement with Oxford University 46
NightstaRx Expands Licensing Agreement with Isis Innovation 47
NightstaRx Enters into Licensing Agreement with Oxford University Innovation 48
Vaccitech Enters into Licensing Agreement with University of Oxford 49
Rogne Bioscience Enters Into Licensing Agreement with Isis Innovation 50
ExpreS2ion Biotech Enters Into Licensing Agreement With University of Oxford For ExpreS2 51
Oxford Nutrascience Enters Into Licensing Agreement With Isis Innovation 52
Summit Therapeutics Raises Funds in Private Placement of Shares upon Exercise of Warrants 53
Evox Therapeutics Spin-Off from University of Oxford 54
Perspectum Diagnostics Raises USD5 Million in Financing 55
Oxstem Spin-Off from University of Oxford 56
University of Oxford, Key Competitors 57
University of Oxford, Key Employees 58
University of Oxford, Subsidiaries 59
University of Oxford, Joint Venture 60
